Thrombomodulin improves early outcomes after intraportal islet transplantation

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1308-1316

  Cui, W ^a   Wilson, J T ^a   Wen, J ^a   Angsana, J ^a   Qu, Z ^a   Haller, C A ^a   Chaikof, E L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia Institute of Technology   (United States)

Author keywords

Engraftment; Inflammation; Islet transplantation; Thrombomodulin; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; FIBRIN; INTERLEUKIN 1BETA; LIPOSOME; THROMBIN; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG FORMULATION; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OUTCOMES RESEARCH; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS TRANSPLANTATION; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED C57BL; THROMBOMODULIN; THROMBOSIS;

EID: 66249133355     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02652.x     Document Type: Article

References (52)

1. Hirshberg B, Rother KI, Harlan DM. Islet transplantation: Where do we stand now? Diabetes Metab Res Rev 2003 19 : 175 178. (Pubitemid 36675956)
2. Brandhorst D, Brandhorst H, Zwolinski A, Nahidi F, Jahr H, Bretzel RG. Primary nonfunction is not caused by accelerated rejection after pig-to-rat islet transplantation. Transplant Proc 1998 30 : 407.
3. Deng S, Ketchum RJ, Kucher T, Weber M, Naji A, Brayman KL. Primary nonfunction of islet xenografts in rat recipients results from non T-cell mediated immune responses. Transplant Proc 1997 29 : 1726.
4. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990 172 : 291 302. (Pubitemid 20217271)
5. Liu X, Hering BJ, Mellert J et al. Prevention of primary nonfunction after porcine islet allotransplantation. Transplant Proc 1997 29 : 2701 2072.
6. Tan M, Di Carlo A, Liu SQ, Tector AJ, Tchervenkov JI, Metrakos P. Hepatic sinusoidal endothelium upregulates IL-1alpha, IFN-gamma, and iNOS in response to discordant xenogeneic islets in an in vitro model of xenoislet transplantation. J Surg Res 2002 102 : 229 236. (Pubitemid 34969472)
7. Berney T, Molano RD, Cattan P et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001 71 : 125 132. (Pubitemid 32105789)
8. Vargas F, Vives-Pi M, Somoza N et al. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 1998 65 : 722 727. (Pubitemid 28128945)
9. Moberg L, Johansson H, Lukinius A et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002 360 : 2039 2045. (Pubitemid 36026584)
10. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002 51 : 1779 1784. (Pubitemid 34564290)
11. Cicala C, Cirino G. Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci 1998 62 : 1817 1824. (Pubitemid 28206666)
12. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000 407 : 258 264.
13. Esmon CT, Gu JM, Xu J, Qu D, Stearns-Kurosawa DJ, Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica 1999 84 : 363 368. (Pubitemid 29474352)
14. Kume M, Hayashi T, Yuasa H et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats - A possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J Hepatol 2003 38 : 9 17. (Pubitemid 36078518)
15. Terada Y, Eguchi Y, Nosaka S, Toba T, Nakamura T, Shimizu Y. Capillary endothelial thrombomodulin expression and fibrin deposition in rats with continuous and bolus lipopolysaccharide administration. Lab Invest 2003 83 : 1165 1173. (Pubitemid 37013051)
16. Arai M, Mochida S, Ohno A et al. Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor. Thromb Res 1995 80 : 113 123.
17. Mochida S, Arai M, Ohno A et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999 29 : 1532 1540. (Pubitemid 29211057)
18. Cui W, Barr G, Faucher KM et al. A membrane-mimetic barrier for islet encapsulation. Transplant Proc 2004 36 : 1206 1208. (Pubitemid 38766324)
19. Haller CA, Cui W, Wen J, Robson SC, Chaikof EL. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties. J Vasc Surg 2006 43 : 816 823.
20. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 1973 244 : 447.
21. Ehrlich HJ, Esmon NL, Bang NU. In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits. J Lab Clin Med 1990 115 : 182 189. (Pubitemid 20084410)
22. Froberg MK, Leone JP, Jessurun J, Sutherland DE. Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum Pathol 1997 28 : 1295 1298. (Pubitemid 27492830)
23. Shapiro AM, Lakey JR, Rajotte RV. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995 59 : 1060 1063.
24. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A 1986 83 : 3460 3464. (Pubitemid 16051992)
25. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986 163 : 740 745. (Pubitemid 16141974)
26. Villiger P, Ryan EA, Owen R et al. Prevention of bleeding after islet transplantation: Lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005 5 : 2992 2998. (Pubitemid 43923962)
27. Bennet W, Sundberg B, Groth CG et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999 48 : 1907 1914. (Pubitemid 29458351)
28. Contreras JL, Eckstein C, Smyth CA et al. Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004 53 : 2804 2814. (Pubitemid 39425905)
29. Hancock WW, Bach FH. Immunobiology and therapeutic applications of protein C/protein S/thrombomodulin in human and experimental allotransplantation and xenotransplantation. Trends Cardiovasc Med 1997 7 : 174 183. (Pubitemid 27329460)
30. Grey ST, Hancock WW. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 1996 156 : 2256 2263. (Pubitemid 26087456)
31. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 1994 153 : 3664 3672. (Pubitemid 24313871)
32. Blakely ML, Van Der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994 58 : 1059 1066. (Pubitemid 24377922)
33. Grinnell BW, Hermann RB, Yan SB. Human protein C inhibits selectin-mediated cell adhesion: Role of unique fucosylated oligosaccharide. Glycobiology 1994 4 : 221 226.
34. Gruber A, Griffin JH, Harker LA, Hanson SR. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 1989 73 : 639 642. (Pubitemid 19069161)
35. Berg DT, Gerlitz B, Shang J et al. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci U S A 2003 100 : 4423 4428. (Pubitemid 36457746)
36. Kumada T, Dittman WA, Majerus PW. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 1988 71 : 728 733. (Pubitemid 18102095)
37. Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. Am J Physiol 1996 271 (3 Pt 1 L470 475.
38. Uchiba M, Okajima K, Murakami K et al. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation. Am J Physiol 1997 273 (4 Pt 1 L889 894.
39. Aoki Y, Ohishi R, Takei R et al. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb Haemost 1994 71 : 452 455. (Pubitemid 24100670)
40. Gonda Y, Hirata S, Saitoh K et al. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 1993 71 : 325 335. (Pubitemid 23222875)
41. Mohri M, Oka M, Aoki Y et al. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 1994 45 : 298 303. (Pubitemid 24109905)
42. Aoki Y, Takei R, Mohri M et al. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats. Am J Hematol 1994 47 : 162 166. (Pubitemid 24333441)
43. Ikeguchi H, Maruyama S, Morita Y et al. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 2002 61 : 490 501. (Pubitemid 34102589)
44. Taoka Y, Okajima K, Uchiba M, Johno M. Neuroprotection by recombinant thrombomodulin. Thromb Haemost 2000 83 : 462 468. (Pubitemid 30148362)
45. Saito H, Maruyama I, Shimazaki S et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007 5 : 31 41.
46. Kearon C, Comp P, Douketis J, Royds R, Yamada K, Gent M. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2005 3 : 962 968. (Pubitemid 41632827)
47. Goto M, Groth CG, Nilsson B, Korsgren O. Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood-mediated inflammatory reaction. Xenotransplantation 2004 11 : 195 202. (Pubitemid 38282270)
48. Goto M, Johansson H, Maeda A, Elgue G, Korsgren O, Nilsson B. Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. Transplant Proc 2004 36 : 1186 1187. (Pubitemid 38766317)
49. Yin D, Ding JW, Shen J, Ma L, Hara M, Chong AS. Liver ischemia contributes to early islet failure following intraportal transplantation: Benefits of liver ischemic-preconditioning. Am J Transplant 2006 6 : 60 68. (Pubitemid 43382201)
50. Abra RM, Hunt CA. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta 1981 666 : 493 503.
51. Galvin JB, Kurosawa S, Moore K, Esmon CT, Esmon NL. Reconstitution of rabbit thrombomodulin into phospholipid vesicles. Journal of Biological Chemistry 1987 262 : 2199 2205.
52. Nakashima M, Kanamaru M, Umemura K, Tsuruta K. Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers. J Clin Pharmacol 1998 38 : 40 44. (Pubitemid 28086722)